|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Randomized phase I1 trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive,human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromataze inhibitors : a GINECO study显示文摘 | Baehelot T Bourgier C Cropet C | 2012 | J Clin Oncol2012，30，22： | 1 |
| 2 | Randomized phase Ⅱ trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aroma- tase inhibitors: a GINECO study显示文摘 | Bachelot T Bourgier C Cropet C | 2012 | J Clin Oncol2012，30，22： | 1 |
| 3 | Randomized phase Ⅱtrial of everolimus in combination with tamoxifen in patients with hormone receptor-positive,human epidermal growth factor receptor 2negative metastatic breast cancer with prior exposure to aromatase inhibitors:a GINECO study显示文摘 | Bachelot T Bourgier C Cropet CA | 2012 | J Clin Oncol2012，30，22： | 1 |
| 4 | Randomized phase Ⅱ trial of Everolimus in combination with Tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: A GINECO study显示文摘 | Bachelol T Bourgier C Cropet C | 2012 | J Clin Oncol2012，30，22： | 1 |
| 5 | Randomized phase II trial of everolimus in combination with tamoxifen in pa- tients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior expo- sure to aromatase inhibitors: a GINECO study显示文摘 | BACHELOT T BOURGIER C CROPET C | 2012 | J Clin Oncol2012，30，22： | 1 |
| 6 | Randomized phase II trial of everolimus in combination with tamoxifen in pa- tients with hormone receptor-positive,human epidermal growth factor receptor 2-negative metastatic breast can- cer with prior exposure to aromatase inhibitors: a GINECO study 显示文摘 | Bachelot T Bourgier C Cropet C | 2012 | J Clin Oncol2012，30，22： | 1 |
| 7 | Randomized phase II trial of everolimus in combination with tamoxifen in patients with hor- mone receptor-positive, human epidermal growth factor receptor 2- negative metastatic breast cancer with prior exposure to arematase inhibitors:a GINECO study 显示文摘 | Bachelot T Bourgier C Cropet C | 2012 | J Clin Oncol2012，30，22： | 1 |
| 8 | Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: a GINECO study显示文摘 | Bachelot T Bourgier C Cropet C | 2012 | J Clin Oncol2012，30，22： | 1 |
| 9 | Randomized phase Ⅱ trial of Everolimus in combination with Tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: A GINECO study显示文摘 | Bachelot T Bourqier C Cropet C | 2012 | J Clin Oncol2012，30，22： | 1 |
| 10 | Lymphopenia as a prognostic factor for overall survival in advanced carcinomas,sarcomas,and lymphomas显示文摘 | Ray-Coquard I Cropet C Van Glabbeke M Sebban C Le Cesne A Judson I Tredan O Verweij J Biron P Labidi I Guastalla JP Bachelot T Perol D Chabaud S Hogendoorn PCW Cassier P Dufresne A Blay JY | 2009 | Cancer Res2009，69，13： | 1 |
| 11 | Randomized Phase II trial of evemlimus in combination with tamoxifen in patients with hormone receptor- positive, human epidermal growth factor receptor 2- negative metastatic breast cancer with prior exposure to aromatase inhibitors: a GINECO study 显示文摘 | BACHELOT T BOURGIER C CROPET C et ol | 2012 | J Clin Oncol2012，30，22： | 1 |
| 12 | Lymphope- nia as a prognostic factor for overall survival in advanced carcino- mas, sarcomas and lymphomas显示文摘 | Ray - Coquard I Cropet C Van Glabbeke M | 2009 | Cancer Res2009，69，13： | 1 |
| 13 | Randomized phase n trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: a GINECO study 显示文摘 | Bachelot T Bourgier C Cropet C | 2012 | J Clin Oncol2012，30，22： | 1 |
| 14 | Lymphopenia as a prognostic factor for overall survival ha advanced carcinomas, sarcomas, and lymphomas显示文摘 | Ray--Coquard I Cropet C Van Glabbeke M | 2009 | Cancer Res2009，69，13： | 1 |
| 15 | Randomized phase IItrial of everolimus in combination with tamoxifen in patients withhormone receptor-positive,human epidermal growth factor re-ceptor 2-negative metastatic breast cancer with prior exposure toaromatase inhibitors:a GINECO study显示文摘 | Bachelot T Bourgier C Cropet C | 2012 | J Clin Oncol2012，30，： | 1 |
| 16 | CD4 lymphopenia to identify end-of-life metastatic cancer patients显示文摘 | Peron J Cropet C Tredan O | 2013 | Eur J Cancer2013，49，5： | 1 |
| 17 | Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive,human epidermal growth factor receptor 2–negative metastatic breast cancer with prior exposure to aromatase inhibitors:a GINECO study显示文摘 | Bachelot T Bourgier C Cropet C | 2012 | J Clin Oncol2012，30，22： | 1 |
| 18 | Randomized PhaseIITrial of Everolimus in Combination With Tamoxifen inPatients With Hormone Receptor-Positive, Human EpidermalGrowth Factor Receptor 2-Negative Metastatic Breast CancerWith Prior Exposure to Aromatase Inhibitors: A GINECOStudy显示文摘 | Bachelot T Bourgier C Cropet C | 2012 | J Clin Oncol2012，30，22： | 1 |
| 19 | Randomized phase U trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 22negative metastatic breast cancer'with prior exposure to aromatase inhibitors : a GINECO study显示文摘 | Bachelot T Bourgier C Cropet C | 2012 | J Clin ()ncol2012，30，22： | 1 |
| 20 | Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth fac- tor receptor 2-negative metastatic breast cancer with prior ex- posure to aromatase inhibitors: a GINECO study显示文摘 | Bachelot T Bourgier C Cropet C | 2012 | J Clin On- col2012，30，22： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员